Low gluten starch diet and nutritional supplementation in two cases of ankylosing spondylitis
DOI:
https://doi.org/10.19230/jonnpr.3014Keywords:
Ankylosing spondylitis / diet therapy, starch, dysbiosis, vit D, orthomolecular therapyAbstract
Ankylosing spondylitis (AS) is a rheumatic disease, inflammatory and progressive, associated with HLAB27 antigen and inflammatory bowel disease (5-10%); such as Crohn's or ulcerative colitis and a higher percentage of cases with AD, are associated with subclinical intestinal inflammations. It is also associated with intestinal permeability and bacterial translocation with fecal presence of Klebsiella pneumoniae.
Celiac disease (CD) and non-celiac gluten sensitivity (SGNC) is strongly related to autoimmune diseases. Several studies support the improvement of AD symptomatology by reducing starch in the diet and gluten.
Low bone mineral density (BMD) is a common comorbidity but poorly appreciated in patients with ankylosing spondylitis (AS), with a prevalence of more than 50% in patients undergoing detection. Vitamin D, in addition to having functions in bone metabolism, has immunoregulatory functions. Nutritional supplements such as quercetin, l-glutamine, pomegranate, n-acetylcysteine, boswellia serrata, curcuma longa, probiotics have proven functions for the improvement of mucosal inflammation and improvement of intestinal permeability.
Objective. To show the efficacy of a diet low in starches and gluten, supported with nutritional supplements such as orthomolecular therapy, to improve intestinal permeability and typical pains in two cases of AD
Method. Two cases were chosen in which the same type of diet and vitamin D supplementation was used. But in each case there was an additional specific supplementation according to the most particular symptoms of each patient.
Conclusions. The diet low in starch and gluten-free together with personalized orthomolecular therapy, can be a treatment to be taken into account in AD as a treatment to help reduce pain and the focus of inflammation, as well as improve intestinal permeability.
Downloads
References
Lianjun Yang 1, Liping Wang 1,2,†OrcID, Xin Wang 3, Cory J. Xian 1,2,* OrcID and Hai Lu 1. A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis. Int J Mol Sci. 2016 Dec; 17(12): 212
Carlos Isasi a,Eva Tejerinab y Luz M. Morán. Sensibilidad al gluten no celíaca y enfermedades reumatológicas. Reumatol Clin. 2016;12(1):4–10
Taha Rashid, Clyde Wilson and Alan Ebringer1. The Link between Ankylosing Spondylitis, Crohn’s Disease, Klebsiella, and Starch Consumption. Clin Dev Immunol. 2013; 2013: 872632.
Ebringer, T. Rashid, H. Tiwana, and C. Wilson, “A possible link between Crohn’s disease and ankylosing spondylitis via Klebsiella infections,” Clinical Rheumatology, vol. 26, no. 3, pp. 289–297, 2007.
Rashid T1, Wilson C, Ebringer A. Raised incidence of ankylosing spondylitis among Inuit populations could be due to high HLA-B27 association and starch consumption. Rheumatol Int. 2015 Jun;35(6):945-51
Ebringer A1, Wilson C. The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis. Clin Rheumatol. 1996 Jan;15 Suppl 1:62-66.
Hayes CE 1 , Nashold FE , Spach KM , Pedersen LB . Las funciones inmunológicas del sistema endocrino de la vitamina D. Celular Mol Biol (Noisy-le-grand). 2003 Mar; 49 (2): 277-300.
Kocyigit BF, Akyol A. Vitamin D levels in patients with ankylosing spondylitis: Is it related to disease activity?. Pak J Med Sci. 2018;34(5):1209-1214.
Rao R, Samak G. Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions. J Epithel Biol Pharmacol. 2011;5(Suppl 1- M7):47-54.
Martínez-González O1, Cantero-Hinojosa J, Paule-Sastre P, Gómez- Magán JC, Salvatierra-Ríos D. Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives. Br J Rheumatol. 1994 Jul;33(7):644-7
Jessica D. Forbes, Gary Van Domselaar and Charles N. Bernstein. The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front Microbiol. 2016; 7: 1081.
Zhang L1, Zhang YJ2, Chen J3, Huang XL2, Fang GS3, Yang LJ2, Duan Y2, Wang J4. The association of HLA-B27 and Klebsiella pneumoniae in ankylosing spondylitis: A systematic review. Microb Pathog. 2018 Apr;117:49-54
Tatiana Sofía Rodríguez-Reyna, Cynthia Martínez-Reyes, Jesús Kazúo Yamamoto-Furusho Rheumatic manifestations of inflammatory bowel disease World J Gastroenterol 2009 November 28; 15(44): 5517-5524
Lerner A, Matthias T. Rheumatoid arthritis-celiac disease relationship: joints get that gut feeling. Autoimmun Rev. 2015 Nov;14(11):1038-47.
Hinze AM, Louie GH. Osteoporosis Management in Ankylosing Spondylitis. Curr Treatm Opt Rheumatol. 2016;2(4):271-282.
Zhao SZ, Thong D, Duffield S, Goodson N. Vitamin D Deficiency in Axial Spondyloarthritis is Associated With Higher Disease Activity. Arch Rheumatol. 2017;32(3):209-215. Published 2017 Mar 24. doi:10.5606/ArchRheumatol.2017.6212
Jeong SY, Im YN, Youm JY, Lee HK, Im SY. l-Glutamine Attenuates DSS-Induced Colitis via Induction of MAPK Phosphatase-1. Nutrients. 2018;10(3):288. Published 2018 Mar 1. doi:10.3390/nu10030288
Zhou Q1,2, Verne ML3, Fields JZ1, Lefante JJ4, Basra S1, Salameh H5, Verne GN1. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2018 Aug 14. pii: gutjnl-2017-315136. doi: 10.1136/gutjnl-2017-31513
Eun CS1, Kim YS, Han DS, Choi JH, Lee AR. Lactobacillus casei prevents impaired barrier function in intestinal epithelial cells. APMIS. 2011 Jan;119(1):49-56. doi: 10.1111/j.1600-0463.2010.02691
Parassol N1, Freitas M, Thoreux K, Dalmasso G, Bourdet-Sicard R, Rampal P. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol. 2005 Mar;156(2):256-62. Epub 2004 Dec 15.
Eun CS 1 , Kim YS , Han DS , Choi JH , Lee AR , Park YK . Lactobacillus casei previene la función de barrera alterada en las células epiteliales intestinales. APMIS. 2011 Ene; 119 (1): 49-56. doi: 10.1111
Kozakova H 1 , Schwarzer M 1 , Tuckova L 1 , Srutkova D 1 , Czarnowska E 2 , Rosiak I 2 and co. Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization. Cell Mol Immunol. 2016 Mar;13(2):251-62. doi: 10.1038/cmi.2015.09. Epub 2015 Mar 23.
Forestier C1, De Champs C, Vatoux C, Joly B. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res Microbiol. 2001 Mar;152(2):167-73.
Governa P1,2, Marchi M3, Cocetta V4, De Leo B5, Saunders PTK6, Catanzaro D7, Miraldi E8, Montopoli M9,10, Biagi M11. Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2. Pharmaceuticals (Basel). 2018 Nov 20;11(4). pii: E126. doi: 10.3390/ph11040126.
Catanzaro D1, Rancan S1, Orso G2, Dall'Acqua S1, Brun P3, Giron MC1, Carrara M1, Castagliuolo I3, Ragazzi E1, Caparrotta L1, Montopoli M1. Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage. PLoS One. 2015 May 8;10(5):e0125375. doi: 10.1371/journal.pone.0125375. eCollection 2015.
Abdel-Tawab M1, Werz O, Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet. 2011 Jun;50(6):349-69. doi: 10.2165/11586800-000000000-00000.
Li Y, Yao J, Han C, et al. Quercetin, Inflammation and Immunity. Nutrients. 2016;8(3):167. Published 2016 Mar 15. doi:10.3390/nu8030167
Yang Y1, Zhang X2, Xu M3, Wu X4, Zhao F5, Zhao C6. Quercetin attenuates collageninduced arthritis by restoration of Th17/Treg balance and activation of Heme Oxygenase 1-mediated anti-inflammatory effect. Int Immunopharmacol. 2018 Jan;54:153-162. doi: 10.1016/j.intimp.2017.11.013. Epub 2017 Nov 14.
Basu A, Schell J, Scofield RH. Dietary fruits and arthritis. Food Funct. 2018;9(1):70-77
Costello, Mary-Ellen & Robinson, Philip & Benham, Helen & A. Brown, Matthew. (2015). Best Practice & Research Clinical Rheumatology. Best Practice & Research Clinical Rheumatology. 29. 202-212. 10.1016/j.berh.2015.08.001.
Hou Y1, Wang L, Yi D, Ding B, Yang Z, Li J, Chen X, Qiu Y, Wu G. N- acetylcysteine reduces inflammation in the small intestine by regulating redox, EGF and TLR4 signaling. Amino Acids. 2013 Sep;45(3):513-22. doi: 10.1007/s00726-012-1295-x. Epub 2012 Apr 25.
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
